Barclays Reaffirms Their Buy Rating on UnitedHealth (UNH)
Wells Fargo Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $677
Wells Fargo Adjusts Price Target on UnitedHealth to $677 From $630, Maintains Overweight Rating
UnitedHealth's Effort to Buy Another Home Health Provider at Risk Amid DOJ Lawsuit
Wells Fargo Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $630
Wells Fargo Keeps Their Buy Rating on UnitedHealth (UNH)
Is UnitedHealth Group Stock (NYSE:UNH) a Buy on the Dip?
UnitedHealth Is Maintained at Overweight by Barclays
UnitedHealth Group Analyst Ratings
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $603
Barclays Reaffirms Their Buy Rating on UnitedHealth (UNH)
UnitedHealth Group Analyst Ratings
TD Cowen Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $609
TD Cowen Initiates UnitedHealth(UNH.US) With Buy Rating, Announces Target Price $609
UnitedHealth: Strategic Growth and Resilience Amid Challenges Justifies Buy Rating
HSBC Downgrades UnitedHealth(UNH.US) to Hold Rating, Raises Target Price to $595
UnitedHealth Downgraded to Hold From Buy at HSBC (Earlier)
A Quick Look at Today's Ratings for UnitedHealth(UNH.US), With a Forecast Between $595 to $650
HSBC Downgrades UnitedHealth to Hold From Buy, Cuts Price Target to $595 From $610
Bernstein Adjusts Price Target on UnitedHealth to $658 From $654